Education
About Us
Working with TipRanks
Follow Us
Zota Health Care Ltd. (IN:ZOTA)
:ZOTA
ZOTA Stock Chart & Stats
₹1533.20
₹23.30(2.41%)
At close: 4:00 PM EST
₹1533.20
₹23.30(2.41%)
Day’s Range― - ―
52-Week Range₹752.00 - ₹1,740.00
Previous CloseN/A
Volume255.13K
Average Volume (3M)68.23K
Market Cap
₹33.50B
Enterprise Value₹35.25B
Total Cash (Recent Filing)₹63.18M
Total Debt (Recent Filing)₹1.81B
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Jun 03, 2026EPS Estimate
-18.4Next Dividend Ex-DateN/A
Dividend Yield0.06%
Share Statistics
EPS (TTM)-8.90
Shares Outstanding30,332,655
10 Day Avg. Volume83,032
30 Day Avg. Volume68,228
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)10.00
Price to Sales (P/S)7.63
P/FCF Ratio-23.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-35.7
Revenue Forecast (FY)₹5.71B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained 62.3% topline growth signals strong product demand and commercial traction. Over the medium term this scale can improve unit economics, fund incremental manufacturing/distribution investments, and provide levers to recover margins if operating efficiency improves.
Healthy Gross MarginsA 53.1% gross margin indicates product-level pricing power and favorable cost of goods dynamics. This structural margin headroom allows the company to cover fixed costs and, if SG&A is controlled, convert revenue growth into sustainable operating profit over time.
Diversified Pharma Revenue StreamsA business model spanning branded/generic sales, contract manufacturing and exports provides multiple durable revenue levers. Geographic and channel diversity reduces single-market risk and supports scale, enabling incremental margins from B2B manufacturing and export expansion.
Bears Say
Ongoing Profitability LossesPersistent negative margins erode retained earnings and limit the company's ability to self-fund growth. Continued operating losses force management to prioritize turnaround actions, constrain investment in R&D/marketing, and raise long-term questions about sustainable competitiveness.
Negative Cash GenerationConsistent negative operating and free cash flow creates reliance on external financing to fund operations and capex. Over months this reduces financial flexibility, may limit capacity expansions, and threatens dividend or shareholder-return plans until cash conversion improves.
Leverage Amid LossesModerate leverage (D/E 0.62) combined with negative ROE increases interest and refinancing risk. With losses, debt amplifies solvency pressure and restricts strategic choices; funding growth without diluting shareholders will be harder until profitability and ROE turn positive.
Zota Health Care Ltd. News
ZOTA FAQ
What was Zota Health Care Ltd.’s price range in the past 12 months?
Zota Health Care Ltd. lowest stock price was ₹752.00 and its highest was ₹1740.00 in the past 12 months.
What is Zota Health Care Ltd.’s market cap?
Zota Health Care Ltd.’s market cap is ₹33.50B.
When is Zota Health Care Ltd.’s upcoming earnings report date?
Zota Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 76 days.
How were Zota Health Care Ltd.’s earnings last quarter?
Zota Health Care Ltd. released its earnings results on Feb 04, 2026. The company reported -₹8.9 earnings per share for the quarter, missing the consensus estimate of N/A by -₹8.9.
Is Zota Health Care Ltd. overvalued?
According to Wall Street analysts Zota Health Care Ltd.’s price is currently Overvalued.
Does Zota Health Care Ltd. pay dividends?
Zota Health Care Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.06%. See more information on Zota Health Care Ltd. dividends here
What is Zota Health Care Ltd.’s EPS estimate?
Zota Health Care Ltd.’s EPS estimate is -18.4.
How many shares outstanding does Zota Health Care Ltd. have?
Zota Health Care Ltd. has 30,332,655 shares outstanding.
What happened to Zota Health Care Ltd.’s price movement after its last earnings report?
Zota Health Care Ltd. reported an EPS of -₹8.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.874%.
Which hedge fund is a major shareholder of Zota Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:ZOTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zota Health Care Ltd.
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
Technical Analysis
Alembic Limited
―
Indoco Remedies Limited
―
Panacea Biotec Limited
―
SMS Pharmaceuticals Limited
―
Solara Active Pharma Sciences Ltd.
―